Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Applying zero based budgeting principles can lead to effective financial management. Learn how to take control of your personal finances.
22,808 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A major fund manager disclosed a sizable exit from a tactical commodity ETF, signaling a shift in market stance. This...
Whispers of a Caesars takeover are fueling a strong price on Kalshi. This article explains what a 68% probability mea...
The battle between FedEx and UPS isn't just about packages—it's about dollars, margins, and future growth. This artic...
CFTC staff released a new FAQ detailing how crypto assets can be used as collateral for derivatives, including specif...
When margins rebound in the energy sector, even senior executives may trim holdings to align with evolving risk and o...
The telehealth scene has been volatile, and the hims hers health stock has seen sharp moves. This guide breaks down w...
Rocket Lab has surged on new contracts and a growing backlog, yet investors wonder if the rally can last. This guide ...
Three nuclear energy stocks that are quietly gaining traction could redefine portfolios in 2026. Explore Fluor, Urani...
A little-known Fidelity fund is posting strong returns as demand for electrification and data-center power infrastruc...
Perplexity's CEO champions a no-fear mindset to seize opportunities as AI disruption reshapes the job market. He repe...
The week brought a roughly 10% drop for Xanadu Quantum Technologies stock as market enthusiasm cools and insiders tra...